Hormones and Cardiovascular Disease
Director: Pierre-Yves Scarabin

 

Hormones and Cardiovascular Disease
Director: Pierre-Yves Scarabin

 

Hormones and Cardiovascular Disease
Director: Pierre-Yves Scarabin

Coordinator : Pierre-Yves Scarabin

The ESTHER group was formed in the 2000s to the Broussais Hospital, Paris, France. This research group was one of the founding teams of the Center of Research Epidemiology and Population Health (CREPH, Villejuif) approved in 2010 by the National Institute of Health and Medical Research (Inserm) and University Paris XI.This group investigates the role of sex hormones in the development of cardiovascular disease. Our research is developed through three scientific projects :

1. Hormonal contraception and venous thromboembolism.

This project aims to assess the impact of different contraceptive methods including progestogen-only pill on haemostatic variables and thrombotic risk, especially among women at high risk for cardiovascular disease.

2. Menopause, hormone therapy and cardiovascular disease.

This program focuses on the safety of transdermal estrogens as well as the impact of progestogens with respect to cardiovascular disease and surrogate markers of atherothrombosis among postmenopausal women.

3. Decline in endogenous sex hormones, cardiovascular disease and dementia in the elderly.

This research area relates to the role of endogenous estrogens and androgens together with other biomarkers in the development of arterial disease and dementia among men and women over 65 years.

© Esther 2019